Jan 08, 2018 12:01 pm UTC| Business
Company Issues Preliminary Fourth Quarter and Full Year 2017 ExpectationsIn Conjunction with J.P. Morgan Healthcare Conference Participation Preliminary Fourth Quarter 2017 Expectations Fourth quarter revenue expected...
Retrophin Provides Corporate Update and 2018 Outlook
Jan 08, 2018 12:01 pm UTC| Business
SAN DIEGO, Jan. 08, 2018 -- Retrophin, Inc. (NASDAQ:RTRX) today announced that, based on preliminary and unaudited financial data, the Company expects net product sales for the fourth quarter of 2017 to be approximately...
Jan 08, 2018 12:01 pm UTC| Business
DUBLIN, Ireland, Jan. 08, 2018 -- Horizon Pharma plc (NASDAQ:HZNP), today announced that it has licensed the global rights to MEDI4945, a pre-clinical, genetically engineered uricase derivative combined with...
SemGroup Corporation to Sell Mexican Asphalt Business for $70 Million
Jan 08, 2018 12:01 pm UTC| Business
TULSA, Okla., Jan. 08, 2018 -- SemGroup® Corporation (NYSE:SEMG) today announced that it has reached an agreement to sell its asphalt business, SemMaterials México, to Ergon Asfaltos México HC, LLC, for an estimated $70...
Jan 08, 2018 12:01 pm UTC| Business
LEIDEN, the Netherlands, Jan. 08, 2018 -- ProQR Therapeutics N.V. (NASDAQ:PRQR), today announced that it has entered into a research collaboration agreement with Galapagos N.V. (Euronext NASDAQ:GLPG). Under the...
Amarillo Appoints Mike Mutchler as President and CEO
Jan 08, 2018 12:01 pm UTC| Business
TORONTO, Jan. 08, 2018 -- Amarillo Gold Corporation (“Amarillo” or the “Company”) (TSX.V:AGC), is pleased to announce the appointment of Mike Mutchler as President CEO and Director of the Company effective immediately....
Jan 08, 2018 12:01 pm UTC| Business
Highly statistically significant results on all primary and secondary endpointsStatistical significance seen as early as day 28, after 4 weeks of treatment in WART-203If approved, A-101 45% would be the first FDA approved...